Effectiveness of lanadelumab for preventing hereditary angioedema attacks: Subgroup analyses from the HELP study. Clin Exp Allergy 2021 Oct;51(10):1391-1395
Date
06/25/2021Pubmed ID
34166549Pubmed Central ID
PMC9290609DOI
10.1111/cea.13974Scopus ID
2-s2.0-85113183008 (requires institutional sign-in at Scopus site) 1 CitationAuthor List
Johnston DT, Busse PJ, Riedl MA, Maurer M, Anderson J, Nurse C, Inhaber N, Yu M, Banerji A, HELP Study InvestigatorsAuthor
Heidi T. Zafra MD Associate Professor in the Pediatrics department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
Angioedemas, HereditaryAntibodies, Monoclonal, Humanized
Humans
Quality of Life
